Benjamin Edwards Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Benjamin Edwards Inc’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Hold	2,197	–	–	﹤0.01%	1172
2026 Q1	$281K	Hold	2,197	–	–	﹤0.01%	1187
2025 Q4	$268K	Hold	2,197	–	–	﹤0.01%	1158
2025 Q3	$220K	Buy	+2,197	New	+$198K	﹤0.01%	1216
2025 Q1	–	Sell	-2,475	Closed	-$223K	–	1173
2024 Q4	$223K	Hold	2,475	–	–	﹤0.01%	1054
2024 Q3	$245K	Buy	+2,475	New	+$243K	﹤0.01%	1011

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Benjamin Edwards Inc's XBI Position: Q2 2026 in Review

Benjamin Edwards Inc held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 2,197 shares worth $348K. The position accounts for ﹤0.01% of the portfolio, ranked #1172.

Benjamin Edwards Inc first reported a position in XBI in Q3 2024 and has held it in 6 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Benjamin Edwards Inc held 2,197 shares of State Street SPDR S&P Biotech ETF worth $348K as of Q2 2026.
Benjamin Edwards Inc left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Benjamin Edwards Inc's portfolio in Q2 2026, its #1172 holding.
Benjamin Edwards Inc first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 6 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Benjamin Edwards Inc's 13F filing for Q2 2026, filed 24 Jul 2026.